Alicia Chung

Alicia Chung is the Sr Vice President of Strategy and Business Development at Bionaut Labs, leading the company’s corporate strategy and business partnerships. Previously, she served as Head of Corporate Development at Amphivena Therapeutics, Inc, a clinical stage immunotherapy company, where she was responsible for the company’s fundraising, partnership transactions, and company operations. Prior to that, Alicia led Strategy and Business Development at Halozyme Therapeutics where she executed out-licensing of Halozyme’s drug delivery technology platform and early stage oncology assets. Alicia began her career at Roche-Genentech, where she held various positions of increasing responsibility in R&D, commercial and business development and licensing.

Location

San Francisco, United States

Links


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Concarlo Holdings

Concarlo is a precision-medicine oncology company focused on diagnosing and treating cancer with an innovative approach to targeting a unique cellular pathway - p27Kip1.


Industries

Headquarters

NY, United States

Employees

11-50

Links